pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,248 catalysts · 3,350 8k filing · 771 grant · 577 earnings · 199 approval · 172 phase 2 completion · 133 drug shortage

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-01×clear all
type
  • 8k filing3,350
  • grant771
  • earnings577
  • approval199
  • phase 2 completion172
  • drug shortage133
device 510k
129
  • device pma74
  • phase 1 completion73
  • phase 2 initiation62
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 20, 2026

    50
    ›Apr 22, 2026drug shortage117d agoBupivacaine Hydrochloride, Epinephrine Bitartrate Injection shortage — Hospira, Inc., a Pfizer CompanyOncoZenge AB

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoSterile Water Injection shortage — Hospira, Inc., a Pfizer Company

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoDexmedetomidine Hydrochloride Injection shortage — Pfizer Inc.PFIZER INC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoMidazolam Hydrochloride Injection shortage — Hospira, Inc., a Pfizer CompanyPAI Holding Co LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoMethotrexate Sodium Injection shortage — Hospira, Inc., a Pfizer CompanyPFIZER INC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoDextrose Monohydrate 50% Injection shortage — Hospira, Inc., a Pfizer Company

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoHeparin Sodium Injection shortage — Hospira, Inc., a Pfizer CompanyPharmacia & Upjohn LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoMorphine Sulfate Injection shortage — Hospira, Inc., a Pfizer CompanyTeva Pharmaceuticals USA Inc

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoSodium Acetate Injection shortage — Hospira, Inc., a Pfizer CompanyAmneal Pharmaceuticals, Inc.

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoPalbociclib Capsule shortage — Pfizer Inc.PFIZER INC

    Status: To Be Discontinued. Reason: not specified. Form: Capsule

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoClindamycin Phosphate Injection shortage — Pfizer Inc.PFIZER INC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoCarboplatin Injection shortage — Hospira, Inc., a Pfizer CompanyOncotelic Therapeutics, Inc.

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoEtomidate Injection shortage — Hospira, Inc., a Pfizer CompanyCaplin Steriles Ltd

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoDobutamine Hydrochloride Injection shortage — Hospira, Inc., a Pfizer CompanySlate Run Pharmaceuticals LLC

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›Apr 22, 2026drug shortage117d agoSufentanil Citrate Injection shortage — Hospira, Inc., a Pfizer CompanyTALPHERA, INC.

    Status: Current. Reason: not specified. Form: Injection

    full page →fda drug shortages ↗
    ›04/23/2026recall116d agoFrederik’s by Meijer recall: Food & Beverages, Allergens

    Vanilla Bourbon Trail Mix

    full page →fda recalls ↗
    ›Apr 23, 20268k filing116d ago$MBRX — Moleculin Biotech, Inc. (MBRX) — 8-K filingMoleculin Biotech, Inc.

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$TECX — Tectonic Therapeutic, Inc. (TECX) — 8-K filingTectonic Therapeutic, Inc.

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$NKTR — NEKTAR THERAPEUTICS (NKTR) — 8-K filingNEKTAR THERAPEUTICS

    Items: 1.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$TNXP — Tonix Pharmaceuticals Holding Corp. (TNXP) — 8-K filingTonix Pharmaceuticals Holding Corp.

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$ZURA — Zura Bio Ltd (ZURA) — 8-K filingZura Bio Ltd

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$INDP — Indaptus Therapeutics, Inc. (INDP) — 8-K filingIndaptus Therapeutics, Inc.

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d agoSemnur Pharmaceuticals, Inc. (SMNR, SMNRW) — 8-K filingSemnur Pharmaceuticals, Inc.

    Items: 1.02

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$BMRN — BIOMARIN PHARMACEUTICAL INC (BMRN) — 8-K filingBIOMARIN PHARMACEUTICAL INC

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$FOLD — AMICUS THERAPEUTICS, INC. (FOLD) — 8-K filingAMICUS THERAPEUTICS, INC.

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$WST — WEST PHARMACEUTICAL SERVICES INC (WST) — 8-K filingWEST PHARMACEUTICAL SERVICES INC

    Items: 2.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$CRVS — Corvus Pharmaceuticals, Inc. (CRVS) — 8-K filingCorvus Pharmaceuticals, Inc.

    Items: 5.02

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$IQV — IQVIA HOLDINGS INC. (IQV) — 8-K filingIQVIA HOLDINGS INC.

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$CNTB — Connect Biopharma Holdings Ltd (CNTB) — 8-K filingConnect Biopharma Holdings Ltd

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$BBOT — BridgeBio Oncology Therapeutics, Inc. (BBOT) — 8-K filingBridgeBio Oncology Therapeutics, Inc.

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$UTMD — UTAH MEDICAL PRODUCTS INC (UTMD) — 8-K filingUTAH MEDICAL PRODUCTS INC

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$ANGO — ANGIODYNAMICS INC (ANGO) — 8-K filingANGIODYNAMICS INC

    Items: 8.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$SGHT — Sight Sciences, Inc. (SGHT) — 8-K filingSight Sciences, Inc.

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$CPIX — CUMBERLAND PHARMACEUTICALS INC (CPIX) — 8-K filingCUMBERLAND PHARMACEUTICALS INC

    Items: 1.01, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$VXRT — Vaxart, Inc. (VXRT) — 8-K filingVaxart, Inc.

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$SSII — SS Innovations International, Inc. (SSII) — 8-K filingSS Innovations International, Inc.

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Apr 23, 20268k filing116d ago$DAWN — Day One Biopharmaceuticals, Inc. (DAWN) — 8-K filingDay One Biopharmaceuticals, Inc.

    Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01

    full page →edgar 8k ↗
    ›Apr 24, 2026patent expiry115d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026patent expiry115d agoEisai Co Ltd — lenvatinib mesylate (Constraining Patent Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 24, 2026drug expiry115d agoDaiichi Sankyo Co Ltd — laninamivir (Drug Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026drug expiry115d agoEisai Co Ltd — lenvatinib mesylate (Drug Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 24, 2026phase 1 completion115d agoLarkspur Biosciences Inc — undisclosed drug (Phase I Trial Completion)undisclosed drug

    Therapy area: Undisclosed. Indication: Unspecified

    full page →undisclosed drug →source: globaldata
    ›Apr 24, 2026phase 1 completion115d agoAkeso Inc — AK-132 (Phase I Trial Completion)AK-132

    Therapy area: Oncology. Indication: Solid Tumor

    full page →AK-132 →source: globaldata
    ›Apr 24, 2026phase 1 initiation115d agoBeijing Friendship Hospital — CMSD-001 (Phase I Trial Initiation)CMSD-001

    Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus

    full page →CMSD-001 →source: globaldata
    ›Apr 24, 2026phase 1 results115d agoWroclaw Medical University — viral-specific T-cells (Phase I Trial Results)viral-specific T-cells

    Therapy area: Hematological Disorders, Infectious Disease, Oncology. Indication: Aplastic Anemia, Cytomegalovirus (HHV-5) Infections, Hemophagocytic Lymphohistiocytosis, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Refractory Acute Myeloid Leukemia, Viral Infections

    full page →viral-specific T-cells →source: globaldata
    ›Apr 24, 2026phase 1 results115d agoMedicus Pharma Ltd — teverelix (Phase I Trial Results)teverelix

    Therapy area: Women's Health. Indication: Endometriosis

    full page →teverelix →source: globaldata
    ›Apr 24, 2026phase 1 results115d agoMedicus Pharma Ltd — teverelix (Phase I Trial Results)teverelix

    Therapy area: Women's Health. Indication: Endometriosis

    full page →teverelix →source: globaldata
    ›Apr 24, 2026phase 1 2 completion115d agoSt. Paul's Hospital — methoxyflurane (Phase I/II Trial Completion)methoxyflurane

    Therapy area: Central Nervous System, Ear Nose Throat Disorders. Indication: Pain, Rhinosinusitis

    full page →methoxyflurane →source: globaldata
    ›Apr 24, 2026phase 1 2 completion115d agoUniversity of Otago — ketamine (Phase I/II Trial Completion)ketamine

    Therapy area: Central Nervous System. Indication: Anxiety Disorders, Post-Traumatic Stress Disorder (PTSD)

    full page →ketamine →source: globaldata
    ›Apr 24, 2026phase 1 2 initiation115d agoMayo Clinic — eflornithine hydrochloride (Phase I/II Trial Initiation)eflornithine hydrochloride

    Therapy area: Oncology. Indication: Anaplastic Astrocytoma, Glioblastoma Multiforme (GBM), High-Grade Glioma, Low-Grade Astrocytoma, Malignant Glioma, Oligodendroglioma

    full page →eflornithine hydrochloride →source: globaldata
    ← prev
    page 28 of 105
    next →
    $OTLC0.0373-8.80%
    $PFE26.79-0.04%
    $AMRX18.15+5.10%
    $TLPH1.2300+1.65%
    $TECX29.56+1.34%
    $PFE26.79-0.04%
    $NKTR73.02-3.82%
    $MBRX2.1000-2.33%
    $PFE26.79-0.04%
    $PFE26.79-0.04%
    $TNXP12.71+1.68%
    $SMNRW0.09000.00%
    $IQV198.52-1.54%
    $ZURA5.6400-0.88%
    $INDP2.7700+4.73%
    $BMRN67.36-1.71%
    $FOLD14.490.00%
    $WST358.41-0.23%
    $CRVS14.89-1.65%
    $CNTB2.2000-0.45%
    $BBOT9.0600-1.84%
    $ANGO13.82-2.81%
    $UTMD69.19+0.06%
    $SGHT5.0300+2.44%
    $VXRT0.5400-3.57%
    $CPIX7.7900-1.39%
    $SSII3.58000.00%
    $DAWN21.530.00%
    $MDCX0.3842+2.59%
    $MDCX0.3842+2.59%